MHUAF.US Meihua International Medical Technologies Co. Ltd.
- Market cap
- USD 5.13M
- P/E
- 0.3x
- P/B
- 0.03x
- ROE
- 7.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is MHUAF.US undervalued?
Graham numberThe Graham number of Meihua International Medical Technologies Co. Ltd. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Meihua International Medical Technologies Co. Ltd. fundamental analysis
No fundamental analysis for Meihua International Medical Technologies Co. Ltd. yet.
Meihua International Medical Technologies Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China, Europe, North America, South America, Asia, Africa, and Oceania. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylen…
Full company profileMeihua International Medical Technologies Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Meihua International Medical Technologies Co. Ltd. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 75.7M | 79.6M | 89.1M | 104M | 103M | 97.1M | 96.9M | 61.8M | 95.2M |
| Gross Profit | 31.9M | 32.2M | 37.2M | 39.8M | 38.1M | 33.1M | 33.3M | 19.0M | 25.9M |
| Operating Income | 19.2M | 19.4M | 23.5M | 26.3M | 10.8M | 14.7M | 14.3M | 8.28M | 20.2M |
| EBITDA | 19.7M | 19.9M | 24.4M | - | 11.6M | 15.8M | 15.7M | 8.83M | 21.3M |
| Net Income | 15.5M | 15.4M | 19.0M | 20.9M | 6.24M | 11.6M | 10.8M | 6.78M | 14.5M |
| EPS | 77 | 64 | 79 | 0.84 | 27 | 49 | 40 | 18 | 21 |
| Balance Sheet | |||||||||
| Total Assets | 62.4M | 73.2M | 106M | 137M | 164M | 172M | 186M | 207M | 207M |
| Total Liabilities | 18.0M | 13.5M | 21.3M | 29.1M | 24.9M | 25.1M | 27.3M | 18.3M | 18.3M |
| Shareholders' Equity | 44.5M | 59.7M | 84.7M | 108M | 138M | 146M | 159M | 189M | 189M |
| Cash & Short-term Investments | 14.8M | 16.0M | 7.19M | 8.15M | 26.7M | 16.9M | 16.0M | 15.2M | 15.2M |
| Total Debt | 2.04M | 2.59M | 3.22M | - | 6.81M | 7.33M | 7.95M | 8.99M | 8.99M |
| Cash Flow | |||||||||
| Operating Cash Flow | 11.8M | 9.31M | 5.33M | -54.7K | -9.16M | 2.28M | 14.6M | 570K | 41.9M |
| Capital Expenditure | 12.3K | 8.95M | 16.1M | 850K | 2.70M | 4.69M | 134K | 15.6K | 21.6K |
| Free Cash Flow | 11.8M | 356K | -10.8M | -905K | -11.9M | -2.41M | 14.5M | 554K | 41.9M |
| Ratios | |||||||||
| ROE | 34.8% | 25.9% | 22.5% | 19.4% | 4.5% | 7.9% | 6.8% | 3.6% | 7.7% |
| ROA | 24.8% | 21.1% | 18.0% | 15.3% | 3.8% | 6.8% | 5.8% | 3.3% | 7.0% |
| Net Profit Margin | 20.4% | 19.4% | 21.4% | 20.1% | 6.0% | 12.0% | 11.2% | 11.0% | 15.3% |
| Debt to Equity | 0.05x | 0.04x | 0.04x | - | 0.05x | 0.05x | 0.05x | 0.05x | 0.05x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Meihua International Medical Technologies Co. Ltd. dividends
Meihua International Medical Technologies Co. Ltd. has not paid dividends in the last 8 fiscal years.
Last stock split: 1:100 on Nov 24, 2025.
Who owns Meihua International Medical Technologies Co. Ltd.
- Insiders 18.57%
- Institutions 0.00%
- Public & others 81.43%
- Shares outstanding 856K
- Free float 566K
Meihua International Medical Technologies Co. Ltd. company profile
- Company name
- Meihua International Medical Technologies Co. Ltd.
- Ticker
- MHUAF.US
- ISIN
- KYG5966G1165
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 486
- Fiscal year end
- December
- Address
- 88 Tongda Road, Yangzhou, China, 225000
- Phone
- 86 51 4898 00199
- Website
- meihuamed.com
About Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China, Europe, North America, South America, Asia, Africa, and Oceania. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, disposable bracelet, tube cleaning brush, gynecological examination and sterile surgical dressing kits, medical hand scrub, cervical sampling swab, catheter, hand washing brush, cervical liquid based cell sampler, surgical hats, suction connecting tube, nasal oxygen tube, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; medical devices, such as medical x-ray films and multi-functional self-extracting X-ray film machines; and provides SaaS development service to develop customized SaaS system covering the entire project lifecycle, including demand analysis, design, research and development, testing, launch, and maintenance support. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. The company was founded in 1991 and is headquartered in Yangzhou, the People's Republic of China.
Meihua International Medical Technologies Co. Ltd. management
2- Ms. Lee LeyiCEO & Director · born 1991
- Mr. Liao ShilongChief Financial Officer · born 1978